On November 7, 2018, NASDAQ displayed on their billboard in New York Times Square the news of the FDA approval of Amphastar's Primatene® MIST.
Board of Directors
Code of Conduct
Copyright © 2022 Amphastar Pharmaceuticals, Inc.
Privacy Terms & Conditions
This site is intended for residents of the United States